Paul Reider - Jan 4, 2024 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Commercial Officer
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Paul Reider
Stock symbol
CHRS
Transactions as of
Jan 4, 2024
Transactions value $
-$6,643
Form type
4
Date filed
1/8/2024, 06:58 PM
Previous filing
Jan 4, 2024
Next filing
Jan 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$6.64K -2.28K -2.57% $2.92 86.1K Jan 4, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.